Isolate
|
Phenotypea
|
MICb(μg/ml)
|
Reference or Comment
|
---|
| |
VCM
|
TEIC
| |
---|
Pair 1
| | | | |
JKD 6000
|
VSSA
|
2.0
|
0.5
|
[12]
|
JKD 6001
|
VISA
|
4.0
|
8.0
|
[12]
|
Pair 2
| | | | |
JKD 6009
|
VSSA
|
1.0
|
0.5
|
[12]
|
JKD 6008
|
VISA
|
4.0
|
2.0
|
[12]
|
Pair 3
| | | | |
JKD 6021
|
VSSA
|
1.0
|
0.25
|
[12]
|
JKD 6023
|
VISA
|
4.0
|
8.0
|
[12]
|
Pair 4
| | | | |
JKD 6052
|
VSSA
|
1.0
|
0.5
|
[12]
|
JKD 6051
|
hVISA
|
2.0
|
4.0
|
[12]
|
Pair 5
| | | | |
JKD 6004
|
VSSA
|
1.0
|
0.5
|
[12]
|
JKD 6005
|
hVISA
|
2.0
|
4.0
|
[12]
|
Pair 6 (control)
| | | | |
JKD 6084
|
VSSA
|
0.5
|
≤ 0.25
|
[this study]
|
JKD 6089
|
VSSA
|
1.0
|
≤ 0.25
|
[this study]
|
Pair 7 (control)
| | | | |
JKD 6090
|
VSSA
|
0.5
|
≤ 0.25
|
[this study]
|
JKD 6094
|
VSSA
|
0.5
|
≤ 0.25
|
[this study]
|
Pair 8 (control)
| | | | |
JKD 6095
|
VSSA
|
1.0
|
0.5
|
[this study]
|
JKD 6097
|
VSSA
|
1.0
|
0.5
|
[this study]
|
Other Isolates
| | | | |
P1
| | | |
Cap8 positive [57]
|
Newman
| | | |
Cap5 positive [57]
|
- aVSSA, vancomycin-susceptible S. aureus; VISA, vancomycin-intermediate S. aureus; hVISA, hetero-VISA.
- bMinimum inhibitory concentration. VCM, vancomycin; TEIC, teicoplanin.